Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2

NCT00363012 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: HER-2/neu intracellular domain protein
OTHER: flow cytometry
OTHER: immunohistochemistry staining method
PROCEDURE: biopsy
OTHER: Sterile water placement

Sponsor

University of Washington

Collaborators

[object Object]